148 related articles for article (PubMed ID: 5061528)
41. [On the resorption of corticoid ointments].
Winkler K
Arch Klin Exp Dermatol; 1966; 227(1):346-7. PubMed ID: 5984780
[No Abstract] [Full Text] [Related]
42. Corticosteroid ointments: comparison by two human bioassays.
Burdick KH; Haleblian JK; Poulsen BJ; Cobner SE
Curr Ther Res Clin Exp; 1973 May; 15(5):233-42. PubMed ID: 4196783
[No Abstract] [Full Text] [Related]
43. [Fluocinonid. A new local corticosteroid, and its vehicles].
Steinacher J
Z Hautkr; 1973 Sep; 48(17):703-10. PubMed ID: 4779150
[No Abstract] [Full Text] [Related]
44. Effects of various vehicles on skin hydration in vivo.
Wiedersberg S; Leopold CS; Guy RH
Skin Pharmacol Physiol; 2009; 22(3):128-30. PubMed ID: 19136833
[TBL] [Abstract][Full Text] [Related]
45. Penetration and action of glucocorticoids.
Schlagel CA
Adv Biol Skin; 1972; 12():339-56. PubMed ID: 4579200
[No Abstract] [Full Text] [Related]
46. [Dynamic observation of topical penetration of substances through the skin barrier].
Salanský I; Valosek P; Dostál M
Cesk Dermatol; 1970 Jan; 45(1):36-41. PubMed ID: 5523624
[No Abstract] [Full Text] [Related]
47. Dermal penetration of 7- 3 H-labelled 3-(2'-chloroethoxy-6-formyl-9 -fluoro- 3,5 -pregnadiene-11 -16 -17 -21-tetrol-20-one-16,17-acetonide-21-acetate after epicutaneous application in the mini-pig.
Baldratti G; Ricevuti G; Minghetti A
Arzneimittelforschung; 1971 Oct; 21(10):1533-5. PubMed ID: 5171880
[No Abstract] [Full Text] [Related]
48. [Corticosteroids: topical cutaneous. Principles and rules of use, posology].
Bonnetblanc JM
Rev Prat; 1996 Jan; 46(1):85-90. PubMed ID: 8596896
[No Abstract] [Full Text] [Related]
49. [Optimal measurement technic for the vasoconstrictor effect of corticosteroids. Comparative studies with reflection photometry and flow measurement].
Gloor M; Sprenger HJ; Priebe L
Dermatol Monatsschr; 1979 Sep; 165(9):665-9. PubMed ID: 527746
[TBL] [Abstract][Full Text] [Related]
50. Fluocinonide--a new topical corticosteroid. Clinical evaluation.
Mendelson CG
Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):63-5. PubMed ID: 5291635
[No Abstract] [Full Text] [Related]
51. [Nipiopharmacology from the dermatologic pint of view].
Gomirato Sandrucci M; Bonu G
Minerva Nipiol; 1968; 18(2):51-60. PubMed ID: 5744924
[No Abstract] [Full Text] [Related]
52. Efficacy of two topical ointments in reducing canine cutaneous flora.
Wooley RE; Hinn JA; Gratzek JB
Vet Med Small Anim Clin; 1970 Feb; 65(2):128-30. PubMed ID: 5198155
[No Abstract] [Full Text] [Related]
53. [Silicon oil as a constituent of dermatological preparations for external use (author's transl)].
Pompe K; Lochman J
Cesk Dermatol; 1976 Aug; 51(4):240-2. PubMed ID: 975268
[No Abstract] [Full Text] [Related]
54. Choosing topical corticosteroids.
Ference JD; Last AR
Am Fam Physician; 2009 Jan; 79(2):135-40. PubMed ID: 19178066
[TBL] [Abstract][Full Text] [Related]
55. Development of in vivo bioequivalence methodology for dermatologic corticosteroids based on pharmacodynamic modeling.
Singh GJ; Adams WP; Lesko LJ; Shah VP; Molzon JA; Williams RL; Pershing LK
Clin Pharmacol Ther; 1999 Oct; 66(4):346-57. PubMed ID: 10546918
[TBL] [Abstract][Full Text] [Related]
56. [Perfection of a method of study of the percutaneous passage of dermatological preparations].
Josse-Azuelle A; Chaumeil JC
Ann Pharm Fr; 1974 Nov; 32(11):581-94. PubMed ID: 4462420
[No Abstract] [Full Text] [Related]
57. [Availability of active substances in and on the skin. Comparative study of the liberation and penetration of various cyproterone and cyproterone acetate ointments].
Kotwas J; Schaefer H; Zesch A
Arzneimittelforschung; 1979; 29(3):562-8. PubMed ID: 582747
[No Abstract] [Full Text] [Related]
58. Déjà vu all over again: skin cap still contains a high-potency glucocorticosteroid.
Swanson DL; Pittelkow MR; Benson LM; Hawkridge AM; Muddiman DC
Arch Dermatol; 2005 Jun; 141(6):801-3. PubMed ID: 15967944
[No Abstract] [Full Text] [Related]
59. [The reactive epidermoplasia of guinea pig skin as a testing method for dermatologic agents].
Weirich EG; Schenk C
Dermatologica; 1969; 139():Suppl II:1+. PubMed ID: 5375539
[No Abstract] [Full Text] [Related]
60. Pimecrolimus permeates less than tacrolimus through normal, inflamed, or corticosteroid-pretreated skin.
Meingassner JG; Aschauer H; Stuetz A; Billich A
Exp Dermatol; 2005 Oct; 14(10):752-7. PubMed ID: 16176283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
